Enzo Biochem Receives Notice of Non-Compliance with New York Stock Exchange Listing Rules
Latest Annual Filing
For Fiscal Year Ending Jul 31, 2024
Quarter Ended October 31, 2024
For Fiscal Year Ending Jul 31, 2024
Enzo Biochem, Inc. has operated as a life sciences company for over 45 years. The primary business of Enzo today is conducted through its Life Sciences division, Enzo Life Sciences, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins. The Company’s proprietary products and technologies play central roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The Company monetizes its technology primarily via sales through our global distribution network and licensing. For more information, please visit enzo.com or follow Enzo Biochem on X and LinkedIn.
Enzo Biochem, Inc.
21 Executive Blvd.
Farmingdale, NY 11735
T: 212-583-0100
Equiniti Trust Company, LLC
T: 1-800-937-5449
helpast@equiniti.com